Bicara Therapeutics Inc. (BCAX)
Market Closed
16 Oct, 08:00 PM
NASDAQ (NMS) NASDAQ (NMS) Primary $
16. 78
-0.84
-4.7673%
$
1.15B Market Cap
- P/E Ratio
- Div Yield
819,996 Volume
0 Eps
$ 17.62
Previous Close 
Want to track BCAX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Bicara Therapeutics Inc. (BCAX) Statistics
Valuation metrics
Market Cap 1.15B
Enterprise value 1.05B
Trailing P/E (ttm) -5.65
Forward P/E -
PEG ratio 0.13
Price/Sales (ttm) -
Price/Book (mrq) 2.54
Enterprise Value/Revenue -
Enterprise Value/EBITDA -5.7
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 716K
Average volume (90 days) 577.67K
Price summary
52-Week low 13.7
52-Week high 30.99
Beta -
50-Day moving average 17.5
200-Day moving average 22.23
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.36%
Return on equity -0.41%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -2.73
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 7.32
Total debt (mrq) -
Total Debt/Equity (mrq) 0
Current ratio (mrq) 11.59%
Book value per share (mrq) 6.9
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
